The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 2013 ACR/ARHP Annual Meeting: Inflammatory Eye Disease Management Can Benefit from Collaboration between Rheumatologists and Ophthalmologists

2013 ACR/ARHP Annual Meeting: Inflammatory Eye Disease Management Can Benefit from Collaboration between Rheumatologists and Ophthalmologists

February 1, 2014 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In scleritis, a rarer condition, almost 60% of cases are due to underlying systemic associations. Rheumatologists must consider scleritis as a possible complication of RA, SLE, ankylosing spondylitis, reactive arthritis, ulcerative colitis, and Sjögren’s syndrome. Diagnosis includes tactile stimulation resulting in increased pain sensation, and therapies may include systemic corticosteroids and potentially steroid-sparing immunomodulatory therapy depending upon the severity of disease and chronicity of ocular inflammation.

You Might Also Like
  • Evolutionary Medicine Provides Insight into the Chronic Inflammatory State Note Rheumatologists at the 2013 ACR/ARHP Annual Meeting
  • Causes of Alopecia Can Vary Among Patients with Systemic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting
  • 2013 ACR/ARHP Annual Meeting: Diagnostic,Treatment Approaches Evolve for Kawasaki Disease
Explore This Issue
February 2014
Also By This Author
  • New Video Shows How to Perform a Lip Biopsy to Diagnose Sjögren’s Syndrome

There are some cases of masquerading syndromes that appear to be inflammatory eye disease but are not, Dr. Papaliodis said. Some conditions that can mimic intraocular inflammation include malignancy and ocular infections, he said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Collaborating with Colleagues

Although rheumatologists are comfortable diagnosing systemic diseases, they may be uncomfortable evaluating the eyes of their patients, said Sergio Schwartzman, MD, associate attending rheumatologist at the Hospital for Special Surgery in New York City. “I believe this is an area where there should be a very close marriage between the rheumatologist and the ophthalmologist, or else patients will suffer,” he stressed.

To diagnose uveitis, a thorough medical history and physical examination, including a slitlamp exam, are most important, Dr. Schwartzman said. An ophthalmologist with experience in treating autoimmune eye diseases should also participate in these patients’ care, he added. Rheumatologists should, at minimum, test for syphilis and tuberculosis, conduct a baseline chest X-ray and routine laboratory tests, and evaluate the patient for Lyme disease. Further testing would be based on the patient’s history and physical exam, he said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Rheumatologists have various challenges in treating their patients who present with these conditions, Dr. Schwartzman said. It is likely that studies of various therapies in autoimmune eye diseases are limited by low patient numbers and trial design. Many ophthalmologists treat uveitis with prolonged corticosteroid therapy, but there is some early evidence to support use of immunosuppressive and remittive medications earlier, he said. In a condition like acute anterior uveitis, which is rarely seen by rheumatologists except in patients with spondylarthropathies, topical steroid drops typically treat the uveitis successfully.

Remittive medications used to treat recalcitrant or “resistant” uveitis include methotrexate, mycophenolate mofetil, azathioprine, cyclosporine, and, rarely, cyclophosphamide. There are few prospective, randomized studies on these therapies and even fewer head-to-head trials, he said. The First-line Antimetabolites as Steroid-sparing Treatment uveitis pilot trial (FAST) was designed to compare oral mycophenolate mofetil with oral methotrexate in uveitis patients who needed corticosteroid-sparing therapy. Results are not yet published.

Other options for treating uveitis include intraocular drug delivery methods such as implants, which bypass the ocular barrier and have become increasingly successful. However, as these are corticosteroid implants, glaucoma and cataracts are possible complications, he noted.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Meeting Reports, Rheumatoid Arthritis Tagged With: ACR/ARHP Annual Meeting, Diagnosis, Inflammatory Eye Disease, iritis, Ophthalmologist, patient care, rheumatologist, Treatment, UveitisIssue: February 2014

You Might Also Like:
  • Evolutionary Medicine Provides Insight into the Chronic Inflammatory State Note Rheumatologists at the 2013 ACR/ARHP Annual Meeting
  • Causes of Alopecia Can Vary Among Patients with Systemic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting
  • 2013 ACR/ARHP Annual Meeting: Diagnostic,Treatment Approaches Evolve for Kawasaki Disease
  • Tips for Treating Pain, Depression in Patients with Rheumatic Disease Offered at the ACR/ARHP’s 2013 Annual Meeting

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)